Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03159546 · ClinicalTrials.gov registry record

FreeStyle Libre Flash Glucose Monitoring System Accuracy

A clinical trial of Diabete Mellitus, sponsored by Abbott Diabetes Care.

Completed
Registry status
50
Enrollment target
4
Study locations

NCT03159546 is a study of Diabete Mellitus that has completed, run by Abbott Diabetes Care. The registered enrollment target is 50 participants, below the 200-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (75% lower). The trial reports 4 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03159546, a study of Diabete Mellitus, has completed, sponsored by Abbott Diabetes Care.

COMPLETED
Registry status
50 participants
Enrollment target
4
Study locations

Study Summary

This is a non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System.

Conditions Studied

Interventions

  • DEVICE Device: FreeStyle Libre Flash Glucose Monitoring System

Study Locations (4)

California

  • William Sansum Diabetes Center - Santa Barbara
  • Diablo Clinical Research - Walnut Creek

Idaho

  • Rocky Mountain Diabetes & Osteoporosis Center - Idaho Falls

Washington

  • Rainier Clinical Research Center - Renton

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-05-13
Est. Completion 2017-08-24

Sponsor

Abbott Diabetes Care

26 total trials

What the Registry Record Tells You About NCT03159546

The ClinicalTrials.gov registry entry for NCT03159546 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 200-participant average among 6 other Diabete Mellitus trials with a reported enrollment target (75% lower). The listed sponsor is Abbott Diabetes Care, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabete Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Device: FreeStyle Libre Flash Glucose Monitoring System is the first listed.

NCT03159546 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Idaho, Washington.

Frequently Asked Questions

What is clinical trial NCT03159546 about?

NCT03159546 is a clinical study titled "FreeStyle Libre Flash Glucose Monitoring System Accuracy". This is a non-randomized, single arm, multi-center, prospective, non-significant risk study to evaluate the FreeStyle Libre Flash Glucose Monitoring System.

What is the current status of trial NCT03159546?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2017-05-13. Estimated completion is 2017-08-24.

What conditions does trial NCT03159546 study?

This clinical trial studies the following conditions: Diabete Mellitus.

What interventions are being tested in trial NCT03159546?

The interventions under investigation include: Device: FreeStyle Libre Flash Glucose Monitoring System (DEVICE).

Who is sponsoring clinical trial NCT03159546?

This trial is sponsored by Abbott Diabetes Care, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03159546 being conducted?

This trial has 4 study locations across California, Idaho, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabete Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.